Share
Erica Rogers
Ceribell, Inc., a medical technology company transforming the diagnosis and management of serious neurological conditions, has appointed Erica Rogers to its Board of Directors.
Ms. Rogers brings over 30 years of experience leading high-growth, innovative medical device companies and supporting Ceribell’s mission to expand timely brain monitoring in acute care settings.
Ms. Rogers is a highly accomplished healthcare executive with board experience in both public and private sectors. She most recently served as CEO of Silk Road Medical, Inc., guiding the company from early-stage development through FDA approval and broad commercial expansion, culminating in its acquisition by Boston Scientific Corporation. During her tenure, the company grew from a 25-person startup to a 500-employee, publicly traded organization with revenue exceeding US$175 million.
A proven innovator and leader, Erica holds multiple patents and has successfully brought numerous products to market. She has also served on the boards of HistoSonics, Axena Health, Sight Sciences, LightForce, and Medicines360, reinforcing her expertise in driving growth and innovation in medtech.
Her appointment strengthens Ceribell’s leadership as the company advances its goal of improving patient access to critical neurological care and expanding its footprint in the medical technology sector.
Related posts
